skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

13 Total results for product and free and sample content found

HBW Insight

Italy's Supplements Market Gets Big Boost From COVID After Solid 2019

hbw-italy-supplement

Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.

Topic Coronavirus Dietary Supplements

HBW Insight

No Evidence That Vitamin D Prevents Or Treats COVID-19

hbw-vitamind

UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.

Topic Coronavirus Dietary Supplements

HBW Insight

Probiotics’ Efficacy Too Specific For General Look In ’60 Minutes’ Segment Critical Of Category

hbw-probiotics

Assertions that no convincing evidence supports that probiotics available in the US treat symptoms of diarrhea, irritable bowel syndrome or allergies look at the category as a whole and not individual strains shown to help with specific conditions, say consumer health industry groups.

Topic Coronavirus Dietary Supplements Research & Development

HBW Insight

US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC

us-covid-fraud

FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.

Topic Coronavirus Dietary Supplements

HBW Insight

CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm

cbd-news

Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.

Topic Dietary Supplements Coronavirus

HBW Insight

Covid-19 Disrupting Supply Chains Short-Term, Could Spark Long-Term Procurement Shifts

Covid19

UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.

HBW Insight

Supplement Industry Summit Postponed, But Sales Jump As Consumers Respond To Covid-19

Corona_virus_masks

Dietary Supplements Regulatory Summit scheduled for 27 May in Washington is postponed. Even as supplies from China are slowed or interrupted due to Covid-19, though, sales of some consumer health products jump as consumers respond to the public health threat.

HBW Insight

No Plans To Remove CBD Products From Shelves, Says UK Food Regulator

No_Plans_To_Remove_CBD_Products_1

CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations. 

HBW Insight

Polish Industry Fighting Against Advertising Tax On Supplements

Polish_Industry_Fighting_Against_Advertising

Advertising dietary supplements in Poland will incur a new tax under proposals from the country's Ministry of Health. While the government claims the motivation is to promote healthy eating choices, industry says supplements have been unfairly linked to poor dietary choices without evidence.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: